Literature DB >> 8362926

On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.

A Tibben1, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage.   

Abstract

We have studied the 6-month follow-up attitudes of 63 individuals, after predictive testing for Huntington disease (HD). Reducing uncertainty (81%) and family planning (60%) were the major reasons for taking the test. Twenty-four individuals were diagnosed as having an increased risk (+/- 98%), and 39 a decreased risk (+/- 2%). Among those with an increased risk, denial or minimization of the ultimate impact of the increased risk result was observed. Most of them (84%) rated their current life situation, at the very least, as being good. Twenty-one percent of individuals with an increased risk who originally planned to have a family, decided to refrain from having children. Sixty percent of those with increased risk who still wished to have children, would choose to have prenatal testing. In most individuals with increased risk, the test result did not increase the previously expected control over their own future. Half of the partners of persons with increased risk acknowledged the burden of the future disease. Half had no one in whom they could confide. They showed loyalty to the denial and avoidance reactions of their spouses. Half of the individuals with decreased risk denied the impact of the result, as reflected by absence of relief, and emotional numbness. A third of persons with decreased risk experienced involvement with problems of affected relatives. We found that 20% of all participants were discontented with the support given by their general practitioner, who is normally regarded as being the most significant professional for aftercare. Our findings suggest that the perpetuation

Entities:  

Mesh:

Year:  1993        PMID: 8362926     DOI: 10.1002/ajmg.1320480209

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  18 in total

1.  Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer.

Authors:  K Aktan-Collan; J P Mecklin; A de la Chapelle; P Peltomäki; A Uutela; H Kääriäinen
Journal:  J Med Genet       Date:  2000-02       Impact factor: 6.318

2.  Intelligence indices in people with a high/low risk for developing Huntington's disease.

Authors:  G M de Boo; A Tibben; J B Lanser; A Jennekens-Schinkel; J Hermans; M Vegter-van der Vlis; R A Roos
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

3.  Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.

Authors:  M Decruyenaere; G Evers-Kiebooms; A Boogaerts; J J Cassiman; T Cloostermans; K Demyttenaere; R Dom; J P Fryns
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

4.  Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.

Authors:  K Lawson; S Wiggins; T Green; S Adam; M Bloch; M R Hayden
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

5.  More appreciation of life or regretting the test? Experiences of living as a mutation carrier of Huntington's disease.

Authors:  Anette Hagberg; The-Hung Bui; Elisabeth Winnberg
Journal:  J Genet Couns       Date:  2010-09-28       Impact factor: 2.537

6.  Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.

Authors:  A C DudokdeWit; A Tibben; H J Duivenvoorden; M F Niermeijer; J Passchier
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

Review 7.  The new genetics. Psychological responses to genetic testing.

Authors:  T M Marteau; R T Croyle
Journal:  BMJ       Date:  1998-02-28

8.  Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test.

Authors:  M K Cho; P Sankar; P R Wolpe; L Godmilow
Journal:  Am J Med Genet       Date:  1999-03-19

9.  Complexities in Cancer Risk Counseling: Presentation of Three Cases.

Authors:  K A Schneider; J E Stopfer; J A Peters; E Knell; G Rosenthal
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

10.  Nonparticipation in Huntington's Disease Predictive Testing: Reasons for Caution in Interpreting Findings.

Authors:  J Binedell; J R Soldan
Journal:  J Genet Couns       Date:  1997-12       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.